MedPath

Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs

Not Applicable
Conditions
Peripheral Pulmonary Nodules
Interventions
Device: Linear Ultrasound Bronchoscope BF-UC290F (Olympus)
Registration Number
NCT05512533
Lead Sponsor
Shanghai Chest Hospital
Brief Summary

The purpose of the study is to evaluate the diagnostic value and safety of Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS) Scope for peripheral pulmonary lesions (PPLs)

Detailed Description

This study will determine the feasibility of the novel thin convex probe endobronchial ultrasound (TCP-EBUS) Scope for the diagnosis of peripheral pulmonary lesions. The primary end point is to clarify the feasibility of using the thin convex probe EBUS scope to biopsy peripheral pulmonary lesions. The secondary objective is to evaluate operation time, sample adequacy and quality, factors affecting the diagnosis rate, etc. The safety, insertion ability, and operability of the thin convex probe EBUS would also be evaluated.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients older than 18 years old.
  • Chest imaging shows the presence of peripheral pulmonary lesions (surrounded by pulmonary parenchyma and located below the segmental bronchus/located at least 2 airway generations from the main carina as seen radiographically.) suspicious of malignancy, 0.8-5cm in greatest diameter in need of bronchoscopic biopsy for clinical purposes, and the investigators consider it possible to be biopsied with BF-UC290F (the bronchus adjacent or leading to the PPLs are ≥5mm in diameter, thus BF-UC290F is able to arrival/access).
  • Patients without contraindications of bronchoscopy.
  • Patients have good medical adherence and signed informed consent.
Exclusion Criteria
  • Peripheral pulmonary lesion is pure ground-glass opacity.
  • Visible lumen lesions during bronchoscopy
  • The lesions were adjacent to the central airway (trachea, left and right main bronchus, and right middle bronchus), and the biopsies by the Thin Convex Probe EBUS Scope BF-UC290F were conducted without leaf bronchus entry
  • The investigators believe that patient has other conditions that are not suitable for the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BF-UC290F for diagnosing PPLsLinear Ultrasound Bronchoscope BF-UC290F (Olympus)Thin EBUS endoscope is inserted and used to visualize peripheral pulmonary lesions, and biopsies will be conducted by EBUS-TBNA.
Primary Outcome Measures
NameTimeMethod
Diagnostic yield of BF-UC290F for PPLsUp to 6 months

Diagnostic yield is defined as the proportion of peripheral pulmonary lesions (PPLs) diagnosed via endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in all lesions undergoing bronchoscopy biopsy via EBUS-TBNA.

Secondary Outcome Measures
NameTimeMethod
EBUS scope operation timeImmediately after each operation

It is defined as the total time from insertion of the EBUS scope to withdrawal of the EBUS scope

The total time of lesion accessImmediately after Each Operation

It is defined as the total time from the insertion of the EBUS scope to the arrival confirmed by ultrasound image.

Factors affecting the diagnosis rateUp to 6 months

Factors affecting the diagnosis rate, including the nature of the lesions, the size of the lesions, the location of the lesions and so on will be analyzed.

The bronchus level of lesions, and the bronchus level reached with the EBUS scopeDuring the procedure

Level: Bronchus is level 0, leaf bronchus is level 1, segment bronchus is level 2, sub-segment bronchus is level 3, and so on, such as: LB3a is level 3

Specimen adequacyUp to 6 months

The adequacy of specimens obtained by Thin Convex Probe EBUS Scope BF-UC290F for pathological typing, molecular testing, and immune checkpoint detection

Trial Locations

Locations (1)

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath